We are live on ! Find out more
CDLX icon

Cardlytics

70 hedge funds and large institutions have $25.1M invested in Cardlytics in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $573K

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.24% less ownership

Funds ownership: 4.27%4.04% (-0.24%)

14% less funds holding

Funds holding: 8170 (-11)

42% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 19

46% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 26

55% less capital invested

Capital invested by funds: $55.3M → $25.1M (-$30.2M)

Holders
70
Holders Change
-11
Holders Change %
-13.58%
% of All Funds
0.85%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
11
Increased
14
Reduced
26
Closed
19
Calls
$1.57M
Puts
$573K
Net Calls
+$995K
Net Calls Change
-$1.77M

CDLX Hedge Fund Activity: Q4 2025 in Review

70 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2025, worth a combined $25.1M — down 55% from $55.3M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CDLX and 11 opened new positions — a net loss of 8 holders — while 26 trimmed existing stakes and 14 added.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $986K. The largest seller was Quinn Opportunity Partners, cutting an estimated $985K.

  • 70 institutional investors held Cardlytics (CDLX) as of Q4 2025, down from 81 in Q3 2025.
  • Funds reported $25.1M of Cardlytics stock for Q4 2025, down 55% quarter-over-quarter.
  • 11 funds opened new Cardlytics positions in Q4 2025 and 19 closed out, a net change of -8 holders.
  • The largest Cardlytics buyer in Q4 2025 was Jacobs Levy Equity Management, an estimated $986K added.
  • The largest Cardlytics seller in Q4 2025 was Quinn Opportunity Partners, an estimated $985K sold.

Based on aggregated 13F filings for Q4 2025.